- ホーム
- > 洋書
- > 英文書
- > Psychology
基本説明
A comprehensive and scholarly review of the current status of the therapeutic potential of hallucinogens.
Full Description
Psychedelic substances present in nature have been used by humans across hundreds of years to produce mind-altering changes in thought, mood, and perception—changes we do not experience otherwise except rarely in dreams, religious exaltation, or psychosis. U.S. scientists were studying the practical and therapeutic uses for hallucinogens, including LSD and mescaline, in the 1950s and 1960s supplied by large manufacturers including Sandoz. But the government took steps to ban all human consumption of hallucinogens, and thus the research. By the 1970s, all human testing was stopped. Medical concerns were not the issue, the ban was motivated by social concerns, not the least of which were created by legendary researcher Timothy Leary, a psychologist who advocated free use of hallucinogens by all who desired. Nationwide, however, a cadre of scholars and researchers has persisted in pushing the federal government to again allow human testing and the moratorium has been lifted. The FDA has begun approving hallucinogenic research using human subjects. In these groundbreaking volumes, top researchers explain the testing and research underway to use—under the guidance of a trained provider—psychedelic substances for better physical and mental health.
Contents
Volume I: Psychedelic Medicine: Social, Clinical and Legal Perspectives Preface Editors Overview of Psychedelic Medicine Section I: The Social and Clinical Context Chapter 1: Introduction: Therapeutic Bases of Psychedelic Medicines: Psychointegrative Effects Chapter 2: The Healing Vine: Ayahuasca as Medicine in the 21st Century Chapter 3: Contemporary Psychedelic Therapy: An Overview Chapter 4: Therapeutic Guidelines: Dangers and Contra-Indications in Therapeutic Applications of Hallucinogens Section II: Medical Applications Chapter 5: Response Of Cluster Headaches to Psilocybin and LSD, Chapter 6: Psilocybin Treatment of Obsessive-Compulsive Disorder Chapter 7: Therapeutic Uses of MDMA Chapter 8: MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder Chapter 9: Psychedelic Drugs for the Treatment of Depression Chapter 10: Marijuana and AIDS Chapter 11: The Use of Psilocybin in Patients with Advanced Cancer and Existential Anxiety Section III: Legal Aspects of the Medical Use Chapter 12: Psychedelic Medicine and the Law Chapter 13: The Legal Bases for Religious Peyote Use Chapter 14: The Supreme Courts Psychedelic Case Chapter 15: Conclusions About the Contributors Volume 2: Psychedelic Medicine: Addictions Medicine and Transpersonal Healing Preface Chapter 1: Introduction Section I: Treating Substance Abuse Chapter 2: Hallucinogens in the Treatment of Alcoholism and Other Addictions Chapter 3: Addiction, Despair, and the Soul: Psychedelic Psychotherapy Chapter 4: The Therapeutic Use of Peyote in the Native American Church Chapter 5: Ibogaine and Substance Abuse Rehabilitation Chapter 6: Ketamine Psychedelic Psychotherapy Chapter 7: Ayahuasca Treatment of Cocaine-Paste Addiction Section II: Guidelines for Psychotherapeutic Applications Chapter 8: The Ten Lessons of Psychedelic Psychotherapy, Rediscovered Chapter 9: Therapeutic Guidelines from Shamanic Traditions Chapter 10: Common Processes in Psychedelic-Induced Psychospiritual Change Chapter 11: Preliminary Remarks on Interpreting Resistance to Psychedelic Insights Section III: Transpersonal Dimension of Healing with Psychedelic Medicines Chapter 12: Psychedelics in Psychological Health and Growth Chapter 13: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Chapter 14: Remarkable Healing During Psychedelic Psychotherapy Chapter 15: Transpersonal Healing with Hallucinogens Chapter 16: Conclusions and Recommendations: The Wider Contexts About the Contributors